Prevalence of fosfomycin resistance among ESBL-producing Escherichia coli isolates in the community, Switzerland

[1]  Fosfomycin , 2019, Reactions Weekly.

[2]  A. Peretz,et al.  High Rates of Fosfomycin Resistance in Gram-Negative Urinary Isolates from Israel. , 2019, Microbial drug resistance.

[3]  Clinical,et al.  Performance standards for antimicrobial susceptibility testing , 2019 .

[4]  V. Cattoir,et al.  How is fosfomycin resistance developed in Escherichia coli? , 2018, Future microbiology.

[5]  A. Widmer,et al.  Basic patient characteristics predict antimicrobial resistance in E. coli from urinary tract specimens: a retrospective cohort analysis of 5246 urine samples. , 2018, Swiss medical weekly.

[6]  P. Nordmann,et al.  Rapid Detection of Fosfomycin Resistance in Escherichia coli , 2018, Journal of Clinical Microbiology.

[7]  J. Madec,et al.  Emergence of blaCTX-M-55 associated with fosA, rmtB and mcr gene variants in Escherichia coli from various animal species in France , 2018, The Journal of antimicrobial chemotherapy.

[8]  M. Rottman,et al.  Emergence of Plasmid-Mediated Fosfomycin-Resistance Genes among Escherichia coli Isolates, France , 2017, Emerging infectious diseases.

[9]  L. Silver.  Fosfomycin: Mechanism and Resistance. , 2017, Cold Spring Harbor perspectives in medicine.

[10]  Zhangqi Shen,et al.  The detection of fosfomycin resistance genes in Enterobacteriaceae from pets and their owners. , 2016, Veterinary microbiology.

[11]  A. Ayad,et al.  Occurence of ArmA and RmtB Aminoglycoside Resistance 16S rRNA Methylases in Extended-Spectrum β-Lactamases Producing Escherichia coli in Algerian Hospitals , 2016, Front. Microbiol..

[12]  V. Cooper,et al.  Glutathione-S-transferase FosA6 of Klebsiella pneumoniae origin conferring fosfomycin resistance in ESBL-producing Escherichia coli. , 2016, The Journal of antimicrobial chemotherapy.

[13]  A. Butt,et al.  Fosfomycin Resistance in Escherichia coli, Pennsylvania, USA , 2015, Emerging infectious diseases.

[14]  S. Hultgren,et al.  Urinary tract infections: epidemiology, mechanisms of infection and treatment options , 2015, Nature Reviews Microbiology.

[15]  Y. Ma,et al.  Characterization of fosA5, a new plasmid‐mediated fosfomycin resistance gene in Escherichia coli , 2015, Letters in applied microbiology.

[16]  K. Kimura,et al.  Practical Agar-Based Disk Potentiation Test for Detection of Fosfomycin-Nonsusceptible Escherichia coli Clinical Isolates Producing Glutathione S-Transferases , 2014, Journal of Clinical Microbiology.

[17]  J. Blázquez,et al.  Molecular Mechanisms and Clinical Impact of Acquired and Intrinsic Fosfomycin Resistance , 2013, Antibiotics.

[18]  Y. Arakawa,et al.  Prevalence of acquired fosfomycin resistance among extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae clinical isolates in Korea and IS26-composite transposon surrounding fosA3. , 2012, The Journal of antimicrobial chemotherapy.

[19]  K. Kimura,et al.  Prevalence of Fosfomycin Resistance among CTX-M-Producing Escherichia coli Clinical Isolates in Japan and Identification of Novel Plasmid-Mediated Fosfomycin-Modifying Enzymes , 2010, Antimicrobial Agents and Chemotherapy.

[20]  M. Falagas,et al.  Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum beta-lactamase producing, Enterobacteriaceae infections: a systematic review. , 2010, The Lancet. Infectious diseases.

[21]  J. Campos,et al.  CTX-M-15-producing urinary Escherichia coli O25b-ST131-phylogroup B2 has acquired resistance to fosfomycin. , 2009, The Journal of antimicrobial chemotherapy.

[22]  K. Laupland,et al.  Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern , 2008 .